Molecular Testing for Long-term Rejection Surveillance in Heart Transplant Recipients: Design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) Trial

Journal of Heart and Lung Transplantation

Volumn 26, Issue 8, 2007, Pages 808-814

  Pham, Michael X ^a,b   Deng, Mario C ^c   Kfoury, Abdallah G ^d   Teuteberg, Jeffrey J ^e   Starling, Randall C ^f   Valantine, Hannah ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c Columbia University ^*  (United States)

^d LDS HOSPITAL   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIAC GRAFT REJECTION; CLINICAL TRIAL; DISEASE SURVEILLANCE; GENE EXPRESSION PROFILING; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HEART GRAFT; INVASIVE MONITORING ATTENUATION THROUGH GENE EXPRESSION TRIAL; MORTALITY; PRIORITY JOURNAL;

CAUSE OF DEATH; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; FOLLOW-UP STUDIES; GENE EXPRESSION; GENE EXPRESSION PROFILING; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INCIDENCE; MOLECULAR DIAGNOSTIC TECHNIQUES; MONITORING, PHYSIOLOGIC; MYOCARDIUM; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34547621475     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.05.017     Document Type: Article

References (25)

1. Hershberger R.E., Starling R.C., Eisen H.J., et al. Daclizumab to prevent rejection after cardiac transplantation. N Engl J Med 352 (2005) 2705-2713
2. Eisen H.J., Tuzcu E.M., Dorent R., et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349 (2003) 847-858
3. White J.A., Guiraudon C., Pflugfelder P.W., and Kostuk W.J. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation. J Heart Lung Transplant 14 (1995) 1052-1056
4. Sethi G.K., Kosaraju S., Arabia F.A., Rosado L.J., McCarthy M.S., and Copeland J.G. Is it necessary to perform surveillance endomyocardial biopsies in heart transplant recipients?. J Heart Lung Transplant 14 (1995) 1047-1051
5. Klingenberg R., Koch A., Schnabel P.A., et al. Allograft rejection of ISHLT grade >/=3A occurring late after heart transplantation-a distinct entity?. J Heart Lung Transplant 22 (2003) 1005-1013
6. Gradek W.Q., D'Amico C., Smith A.L., Vega D., and Book W.M. Routine surveillance endomyocardial biopsy continues to detect significant rejection late after heart transplantation. J Heart Lung Transplant 20 (2001) 497-502
7. Winters G.L., Costanzo-Nordin M.R., O'Sullivan E.J., et al. Predictors of late acute orthotopic heart transplant rejection. Circulation 80 (1989) III-106-III-110
8. Stehlik J., Starling R.C., Movsesian M.A., et al. Utility of long-term surveillance endomyocardial biopsy: a multi-institutional analysis. J Heart Lung Transplant 25 (2006) 1402-1409
9. Radovancevic B., Konuralp C., Vrtovec B., et al. Factors predicting 10-year survival after heart transplantation. J Heart Lung Transplant 24 (2005) 156-159
10. Brunner-La Rocca H.P., Schneider J., Kunzli A., Turina M., and Kiowski W. Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease. Transplantation 65 (1998) 538-543
11. Caves P.K., Stinson E.B., Billingham M., and Shumway N.E. Percutaneous transvenous endomyocardial biopsy in human heart recipients. Experience with a new technique. Ann Thorac Surg 16 (1973) 325-336
12. Baraldi-Junkins C., Levin H.R., Kasper E.K., Rayburn B.K., Herskowitz A., and Baughman K.L. Complications of endomyocardial biopsy in heart transplant patients. J Heart Lung Transplant 12 (1993) 63-67
13. Williams M.J., Lee M.Y., DiSalvo T.G., et al. Biopsy-induced flail tricuspid leaflet and tricuspid regurgitation following orthotopic cardiac transplantation. Am J Cardiol 77 (1996) 1339-1344
14. Oldham N., Ott R.A., Allen B.A., Fopiano P., and Dwyer M. Ventricular fibrillation complicating endomyocardial biopsy of a cardiac allograft. Cathet Cardiovasc Diagn 23 (1991) 300-301
15. Cui G., Kobashigawa J., Margarian A., and Sen L. Cause of atrioventricular block in patients after heart transplantation. Transplantation 76 (2003) 137-142
16. Evans R.W., Williams G.E., Baron H.M., et al. The economic implications of noninvasive molecular testing for cardiac allograft rejection. Am J Transplant 5 (2005) 1553-1558
17. Marboe C.C., Billingham M., Eisen H., et al. Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients. J Heart Lung Transplant 24 suppl (2005) S219-S226
18. Kubo S.H., Naftel D.C., Mills Jr. R.M., et al., Cardiac Transplant Research Database Group. Risk factors for late recurrent rejection after heart transplantation: a multiinstitutional, multivariable analysis. J Heart Lung Transplant 14 (1995) 409-418
19. Kirklin J.K., Naftel D.C., Bourge R.C., et al. Rejection after cardiac transplantation. A time-related risk factor analysis. Circulation 86 suppl (1992) II-236-II-241
20. Horwitz P.A., Tsai E.J., Putt M.E., et al. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation 110 (2004) 3815-3821
21. Schoels M., Dengler T.J., Richter R., Meuer S.C., and Giese T. Detection of cardiac allograft rejection by real-time PCR analysis of circulating mononuclear cells. Clin Transplant 18 (2004) 513-517
22. Deng M.C., Eisen H.J., Mehra M.R., et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 6 (2006) 150-160
23. Starling R.C., Pham M., Valantine H., et al. Molecular testing in the management of cardiac transplant recipients: initial clinical experience. J Heart Lung Transplant 25 (2006) 1389-1395
24. Chen Y.H., DeMets D.L., and Lan K.K. Increasing the sample size when the unblinded interim result is promising. Stat Med 23 (2004) 1023-1038
25. Mills R.M., Naftel D.C., Kirklin J.K., et al. Heart transplant rejection with hemodynamic compromise: a multiinstitutional study of the role of endomyocardial cellular infiltrate. Cardiac Transplant Research Database. J Heart Lung Transplant 16 (1997) 813-821